13F
中

CPRX CATALYST PHARMACEUTICALS INC

2026Q1 · CUSIP 14888U101 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
377
Δ holders QoQ
+4
Breadth percentile
Top 46%
Whale holders
173
Δ whales
+8
Inst. holding value
$2.6B
New positions
56
Closed positions
52
Price momentum (1Q)
+26.7%
Put / Call
4/4

Breadth history (34 quarters)

2018Q1: Δ-7 · h=98 2018Q2: Δ+0 · h=98 2018Q3: Δ+0 · h=98 2018Q4: Δ-11 · h=87 2019Q1: Δ+2 · h=89 2019Q2: Δ+11 · h=100 2019Q3: Δ+18 · h=118 2019Q4: Δ+14 · h=132 2020Q1: Δ+1 · h=133 2020Q2: Δ+9 · h=142 2020Q3: Δ+2 · h=144 2020Q4: Δ-7 · h=137 2021Q1: Δ-2 · h=135 2021Q2: Δ+7 · h=142 2021Q3: Δ+3 · h=145 2021Q4: Δ+21 · h=166 2022Q1: Δ+21 · h=187 2022Q2: Δ+5 · h=192 2022Q3: Δ+38 · h=230 2022Q4: Δ+30 · h=260 2023Q1: Δ+1 · h=261 2023Q2: Δ-11 · h=250 2023Q3: Δ+7 · h=257 2023Q4: Δ+3 · h=260 2024Q1: Δ+8 · h=268 2024Q2: Δ+5 · h=273 2024Q3: Δ+43 · h=316 2024Q4: Δ+23 · h=339 2025Q1: Δ+27 · h=366 2025Q2: Δ+0 · h=366 2025Q3: Δ-5 · h=361 2025Q4: Δ+12 · h=373 2026Q1: Δ+4 · h=377 2018Q1: holders=98 2018Q2: holders=98 2018Q3: holders=98 2018Q4: holders=87 2019Q1: holders=89 2019Q2: holders=100 2019Q3: holders=118 2019Q4: holders=132 2020Q1: holders=133 2020Q2: holders=142 2020Q3: holders=144 2020Q4: holders=137 2021Q1: holders=135 2021Q2: holders=142 2021Q3: holders=145 2021Q4: holders=166 2022Q1: holders=187 2022Q2: holders=192 2022Q3: holders=230 2022Q4: holders=260 2023Q1: holders=261 2023Q2: holders=250 2023Q3: holders=257 2023Q4: holders=260 2024Q1: holders=268 2024Q2: holders=273 2024Q3: holders=316 2024Q4: holders=339 2025Q1: holders=366 2025Q2: holders=366 2025Q3: holders=361 2025Q4: holders=373 2026Q1: holders=377 -43 -21.5 +0 +21.5 +43 78237396 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 7 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 7% -17.8% -8.4%
2024Q3 Top 5% +3.8% +15.8%
2022Q4 Top 13% -19.8% -5.1%
2022Q3 Top 1% +1.9% -20.1%
2022Q1 Top 8% +91.5% +121.6%
2019Q3 Top 9% +14.5% -1.5%
2019Q2 Top 13% -18.4% -10.9%

Options Sentiment

Put holders
4
QoQ: +2
Call holders
4
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
18.2
EPS (TTM)
$1.73
EPS YoY
+10.2%
Revenue (TTM)
$0.6B
Revenue YoY
+11.7%
Quarterly Revenue & EPS (4Y)
2022-06-30: $53M 2022-09-30: $57M 2022-12-31: $61M 2023-03-31: $85M 2023-06-30: $100M 2023-09-30: $103M 2023-12-31: $111M 2024-03-31: $99M 2024-06-30: $123M 2024-09-30: $129M 2024-12-31: $142M 2025-03-31: $141M 2025-06-30: $147M 2025-09-30: $148M 2025-12-31: $153M 2026-03-31: $149M 2022-06-30: EPS 0.20 2022-09-30: EPS 0.20 2022-12-31: EPS 0.23 2023-03-31: EPS 0.26 2023-06-30: EPS 0.33 2023-09-30: EPS -0.29 2023-12-31: EPS 0.33 2024-03-31: EPS 0.19 2024-06-30: EPS 0.33 2024-09-30: EPS 0.35 2024-12-31: EPS 0.44 2025-03-31: EPS 0.45 2025-06-30: EPS 0.41 2025-09-30: EPS 0.42 2025-12-31: EPS 0.40 2026-03-31: EPS 0.50 0M 76M 153M $M -0.32 0.12 0.55 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 17 2023-03-31: PE 14.12023-06-30: PE 14.52023-09-30: PE 25.22023-12-31: PE 22.22024-03-31: PE 29.42024-06-30: PE 35.52024-09-30: PE 17.22024-12-31: PE 17.82025-03-31: PE 15.52025-06-30: PE 12.32025-09-30: PE 13.52025-12-31: PE 14.52026-03-31: PE 18 11 24 37 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)